Chris Hannay
@hannay.bsky.social
đ€ 5197
đ„ 283
đ 13
Health and business reporter at The Globe and Mail
reposted by
Chris Hannay
The Globe and Mail
3 days ago
loading . . .
MPs urge non-profit behind PrescribeIT to submit overdue documents to parliamentary committee
Infoway says it supplied the majority of the documents on time, but the remainder cover a âbroad range of historical recordsâ that could include hundreds of thousands of pages
https://www.theglobeandmail.com/business/economy/article-prescribeit-infoway-submit-overdue-documents/?utm_source=dlvr.it&utm_medium=bluesky
1
5
3
reposted by
Chris Hannay
The Globe and Mail
4 days ago
loading . . .
Health Canada examining concerns of family of student who died after plasma donation, minister says
Calls for more scrutiny of the circumstances surrounding the death at the for-profit donation centre came after the governmentâs initial report
https://www.theglobeandmail.com/canada/article-health-canada-student-death-plasma-donation-family-concerns-minister/?utm_source=dlvr.it&utm_medium=bluesky
0
2
1
reposted by
Chris Hannay
The Globe and Mail
5 days ago
loading . . .
Why Ottawaâs $298-million âaxe the faxâ program PrescribeIT failed
Digital prescription program suffered from slow enrolment process, lack of national buy-in
https://www.theglobeandmail.com/canada/article-why-axe-the-fax-program-prescribeit-failed/?utm_source=dlvr.it&utm_medium=bluesky
1
3
5
reposted by
Chris Hannay
The Globe and Mail
9 days ago
loading . . .
Apotex expected to fetch $10-billion valuation as drugmaker files to go public on TSX
Toronto company founded by the late Barry Sherman expected to become Canadaâs most valuable public life sciences company
https://www.theglobeandmail.com/business/economy/article-apotex-expected-to-fetch-10-billion-valuation-as-drugmaker-files-to-go/?utm_source=dlvr.it&utm_medium=bluesky
1
3
2
reposted by
Chris Hannay
The Globe and Mail
11 days ago
loading . . .
Ozempic maker cuts brand-name price as generic semaglutide hits pharmacy shelves
Torontoâs Apotex prices its version of Ozempic at less than a third of the cost of the brand-name product
https://www.theglobeandmail.com/business/economy/article-ozempic-price-brand-name-drug-generic-semaglutide-weight-loss/?utm_source=dlvr.it&utm_medium=bluesky
0
20
14
reposted by
Chris Hannay
The Globe and Mail
11 days ago
loading . . .
Health Canada to inspect three Grifols private plasma collection sites in Ontario
Locations in Toronto and Cambridge havenât been inspected since opening last year
https://www.theglobeandmail.com/canada/article-health-canada-inspect-three-grifols-blood-plasma-collection-sites/?utm_source=dlvr.it&utm_medium=bluesky
0
7
2
reposted by
Chris Hannay
André Picard @picardonhealth
13 days ago
Health Canada urged to inspect three Grifols sites in Ontario amid safety concerns. Ontario NDP MP says inspection system hasn't adapted to rise in for-profit blood collection, by
@hannay.bsky.social
www.theglobeandmail.com/canada/artic...
via
@theglobeandmail.com
loading . . .
Health Canada urged to inspect three Grifols sites in Ontario amid safety concerns
Ontario NDP MPP says inspection system hasnât adapted to rise in for-profit blood collection
https://www.theglobeandmail.com/canada/article-health-canada-urged-to-inspect-three-grifols-sites-in-ontario/
0
11
11
reposted by
Chris Hannay
The Globe and Mail
17 days ago
loading . . .
Family of plasma donor who died calls for investigation over record inconsistencies
Rodiyat Alabede, 22, died after donating plasma at a Grifols collection centre in Winnipeg
https://www.theglobeandmail.com/canada/article-plasma-donation-winnipeg-grifols-investigation-record-inconsistencies/?utm_source=dlvr.it&utm_medium=bluesky
1
6
3
reposted by
Chris Hannay
The Globe and Mail
18 days ago
loading . . .
Conservatives call for tighter Health Canada oversight of plasma centres after two deaths
Two donors have died in recent months after giving plasma at Grifolsâ clinics in Winnipeg
https://www.theglobeandmail.com/canada/article-conservatives-call-for-tighter-health-canada-oversight-of-plasma/?utm_source=dlvr.it&utm_medium=bluesky
0
10
4
reposted by
Chris Hannay
The Globe and Mail
20 days ago
loading . . .
Health Canada found multiple issues at Grifolsâ Winnipeg clinic after death, inspector report shows
Document suggests federal health agency pointed out some of the same concerns repeatedly since 2022 without resolution
https://www.theglobeandmail.com/canada/article-health-canada-issues-grifols-winnipeg-inspector-report/?utm_source=dlvr.it&utm_medium=bluesky
0
50
3
reposted by
Chris Hannay
The Globe and Mail
24 days ago
loading . . .
Canadiansâ plasma is now a liquid asset. Is that ethical? I donated to learn more
For years, Canadians werenât paid for a prized medical resource in their veins. Now, some are
https://www.theglobeandmail.com/business/economy/article-plasma-blood-services-donation-grifols/?utm_source=dlvr.it&utm_medium=bluesky
1
4
2
reposted by
Chris Hannay
The Globe and Mail
about 1 month ago
loading . . .
Board chair of non-profit behind failed PrescribeIT defends CEOâs nearly $900,000 compensation
Pay was justified because it was on par with hospital executives, Peter Vaughan tells MPs
https://www.theglobeandmail.com/canada/article-prescribeit-ceo-nonprofit-compensation-health-committee/?utm_source=dlvr.it&utm_medium=bluesky
2
8
4
reposted by
Chris Hannay
The Globe and Mail
about 1 month ago
loading . . .
Health Canada approves generic Ozempic from Apotex, countryâs largest drug maker
Apotex is first company to get approval that has domestic manufacturing presence
https://www.theglobeandmail.com/business/economy/article-health-canada-apotex-generic-ozempic-approval/?utm_source=dlvr.it&utm_medium=bluesky
0
11
4
reposted by
Chris Hannay
The Globe and Mail
about 1 month ago
loading . . .
Head of non-profit paid nearly $900,000 a year despite failure of federal âaxe the faxâ program
Failed program is under scrutiny for lack of uptake despite $300-million in federal funds spent
https://www.theglobeandmail.com/business/economy/article-prescribeit-axe-the-fax-executive-salary/?utm_source=dlvr.it&utm_medium=bluesky
0
7
5
reposted by
Chris Hannay
The Globe and Mail
about 1 month ago
loading . . .
Health regulator authorizes Indian company to sell first generic Ozempic in Canada
Dr. Reddyâs Laboratories Ltd. has been authorized to sell the drug, Health Canada says
https://www.theglobeandmail.com/business/economy/article-generic-ozempic-glp1-approved-health-canada/?utm_source=dlvr.it&utm_medium=bluesky
0
13
4
reposted by
Chris Hannay
The Globe and Mail
about 1 month ago
loading . . .
Conservative MPs call on Auditor-General to probe federal spending on failed digital prescription program
PrescribeIT service that cost nearly $300-million in federal funds was cancelled in February after few doctors used it
https://www.theglobeandmail.com/business/article-conservative-mps-auditor-general-prescribeit-probe/?utm_source=dlvr.it&utm_medium=bluesky
0
6
4
reposted by
Chris Hannay
The Globe and Mail
about 1 month ago
loading . . .
How Novel veterinary clinic tries to lower bills and empower employees
Burlington clinic includes an optional membership plan for clients
https://www.theglobeandmail.com/business/economy/article-how-novel-veterinary-clinic-tries-to-lower-bills-and-empower-employees/?utm_source=dlvr.it&utm_medium=bluesky
2
11
3
reposted by
Chris Hannay
The Globe and Mail
about 2 months ago
loading . . .
MPs press official on why $250-million âaxe the faxâ digital prescribing program failed
CEO Michael Green struggled to provide satisfactory answers to questions about PrescribeITâs budget
https://www.theglobeandmail.com/business/economy/article-mps-press-official-on-why-250-million-axe-the-fax-digital-prescribing/?utm_source=dlvr.it&utm_medium=bluesky
1
8
6
reposted by
Chris Hannay
The Globe and Mail
about 2 months ago
loading . . .
Public health plans should cover Mounjaro for type 2 diabetes, Canadaâs Drug Agency recommends
Non-binding recommendation comes with stipulation that Eli Lilly offer the drug at a discount
https://www.theglobeandmail.com/business/economy/article-canada-drug-agency-mounjaro-recommendation-type-2-diabetes/?utm_source=dlvr.it&utm_medium=bluesky
1
5
1
reposted by
Chris Hannay
The Globe and Mail
about 2 months ago
loading . . .
Apotex wins tentative FDA approval for generic Ozempic, drug makers await Health Canada decisions
U.S. market will not open till patent expires in 2032, but individual generics can be sold in Canada once approved
https://www.theglobeandmail.com/business/economy/article-apotex-fda-approval-generic-ozempic-drug-health-canada-decisions/?utm_source=dlvr.it&utm_medium=bluesky
0
13
3
reposted by
Chris Hannay
André Picard @picardonhealth
about 2 months ago
Government probes into deaths of two plasma donors find no link to Grifolsâ donation process. Advocates call for inquiry into company's operations, by
@temurdur.bsky.social
@hannay.bsky.social
www.theglobeandmail.com/canada/artic...
via
@theglobeandmail.com
loading . . .
Government probes into deaths of two plasma donors find no link to Grifolsâ donation process
Advocate calls for formal inquiry into companyâs operations, citing concerns over Health Canadaâs investigation of the deaths
https://www.theglobeandmail.com/canada/article-government-probes-into-deaths-of-two-plasma-donors-find-no-link-to/
1
5
3
reposted by
Chris Hannay
The Globe and Mail
2 months ago
loading . . .
Ottawa, drug companies launch task force to prepare for USMCA talks
Group plans to meet every two weeks and prepare a report in 90 days with options for Canadaâs response
https://www.theglobeandmail.com/business/economy/article-ottawa-drug-companies-launch-task-force-to-prepare-for-usmca-talks/?utm_source=dlvr.it&utm_medium=bluesky
0
3
4
reposted by
Chris Hannay
The Globe and Mail
2 months ago
loading . . .
Health Canada imposes new conditions on Grifols after deaths of two people who donated plasma
Regulator says Grifols centres must reduce number of appointments, better supervise new staff and improve donor records
https://www.theglobeandmail.com/canada/article-grifols-health-canada-terms-conditions-blood-plasma/?utm_source=dlvr.it&utm_medium=bluesky
0
4
1
reposted by
Chris Hannay
The Globe and Mail
2 months ago
loading . . .
Grifols donors not informed their plasma is used for drugs sold overseas, MPs hear
VP tells House of Commons committee that donors are informed of risk of death during the procedure
https://www.theglobeandmail.com/canada/article-grifols-donors-plasma-drugs-sold-overseas-mps-hear/?utm_source=dlvr.it&utm_medium=bluesky
0
9
5
reposted by
Chris Hannay
The Globe and Mail
2 months ago
loading . . .
Why Canada spends $1-billion a year on drugs made from blood plasma
Demand growing for immunoglobulin to address immune deficiencies that can result from cancer treatment
https://www.theglobeandmail.com/business/economy/article-canadian-blood-services-budget-plasma/?utm_source=dlvr.it&utm_medium=bluesky
0
10
4
reposted by
Chris Hannay
The Globe and Mail
3 months ago
loading . . .
Generic Ozempic makes debut in India, ahead of Canada where it became legal months ago
Generic versions of diabetes and weight-loss drug became legal in early January
https://www.theglobeandmail.com/business/economy/article-generic-ozempic-makes-debut-in-india-ahead-of-canada-where-it-became/?utm_source=dlvr.it&utm_medium=bluesky
0
11
5
reposted by
Chris Hannay
The Globe and Mail
3 months ago
loading . . .
Ontario to create electronic medical record system to streamline patient data sharing
Centralized record-keeping system would allow GPs to more easily access health care data
https://www.theglobeandmail.com/canada/article-ontario-health-care-record-keeping-medical-system/?utm_source=dlvr.it&utm_medium=bluesky
4
5
4
reposted by
Chris Hannay
The Globe and Mail
3 months ago
loading . . .
Loved ones seek answers after 22-year-old student dies while donating plasma at for-profit site in Winnipeg
Health Canada says four such deaths have occurred in the last 10 years, as Manitoba mulls a ban on the practice
https://www.theglobeandmail.com/canada/article-loved-ones-seek-answers-after-22-year-old-student-dies-while-donating/?utm_source=dlvr.it&utm_medium=bluesky
0
7
4
reposted by
Chris Hannay
The Globe and Mail
3 months ago
loading . . .
Health Canada reviewing deaths of two people who donated plasma at private centres in Winnipeg
Grifols, which runs the centres, says itâs co-operating with the government and doing its own investigation
https://www.theglobeandmail.com/business/economy/article-health-canada-grifols-plasma-winnipeg/?utm_source=dlvr.it&utm_medium=bluesky
0
9
8
reposted by
Chris Hannay
The Globe and Mail
3 months ago
loading . . .
Ottawa should prioritize reviews and procurement of Canadian-made drugs, manufacturers say
Actions of Trump administration, other jurisdictions driving major shift in how drugs are made, Apotex CEO says
https://www.theglobeandmail.com/business/economy/article-ottawa-should-prioritize-reviews-and-procurement-of-canadian-made/?utm_source=dlvr.it&utm_medium=bluesky
1
10
2
reposted by
Chris Hannay
The Globe and Mail
3 months ago
loading . . .
U.S. FDA says it met with states interested in importing cheaper drugs from Canada
Program has been met with disapproval from Ottawa
https://www.theglobeandmail.com/business/economy/article-us-fda-says-it-met-with-states-interested-in-importing-cheaper-drugs/?utm_source=dlvr.it&utm_medium=bluesky
6
13
9
reposted by
Chris Hannay
The Globe and Mail
3 months ago
loading . . .
What will change in Canada when generic Ozempic hits the market, according to our reporters
Readers asked about GLP-1 side effects, weight loss while on Ozempic and insurance coverage
https://www.theglobeandmail.com/life/article-ozempic-wegovy-mounjaro-side-effects-weight-loss-glp-1/?utm_source=dlvr.it&utm_medium=bluesky
1
9
3
reposted by
Chris Hannay
André Picard @picardonhealth
3 months ago
Skinny, Inc. Part 2: The big business of Ozempic. How generic semaglutide will mean lower prices and more options, w/
@hannay.bsky.social
,
@kellygrant1.bsky.social
, Kasia Mychajlowycz
www.theglobeandmail.com/podcasts/the...
www.theglobeandmail.com/business/eco...
via
@theglobeandmail.com
loading . . .
Canada will be a launching pad in the global race for generic Ozempic
Six pharmaceutical companies have applied to make a generic version of semaglutide, and competition will continue to heat up in the rapidly growing weight-loss market
https://www.theglobeandmail.com/business/economy/article-generic-ozempic-canada-drugmakers/
0
8
1
reposted by
Chris Hannay
The Globe and Mail
3 months ago
loading . . .
Ottawa says provinces should pay for nurse practitioners, gives one-year grace before penalties
New policy amounts to one of the most significant updates of the Canada Health Act in years
https://www.theglobeandmail.com/business/economy/article-ottawa-says-provinces-should-pay-for-nurse-practitioners-gives-one/?utm_source=dlvr.it&utm_medium=bluesky
4
15
8
reposted by
Chris Hannay
Susan Krashinsky Robertson
4 months ago
Online pharmacy services have boomed, and advertisements for quick access to in-demand drugs are all over social media. But many of these promotions are violating Canadian regulations on prescription-drug advertising, a Globe and Mail analysis has found.
www.theglobeandmail.com/canada/artic...
loading . . .
Dozens of online-pharmacy ads, including for weight-loss drugs, appear to violate federal rules
By making certain promises to customers, some companies are running afoul of Canadian drug advertising laws
https://www.theglobeandmail.com/canada/article-skinny-inc-online-pharmacy-ads-weight-loss-drugs-federal-rules/
0
1
1
reposted by
Chris Hannay
The Globe and Mail
4 months ago
loading . . .
Dozens of online-pharmacy ads, including for weight-loss drugs, appear to violate federal rules
By making certain promises to customers, some companies are running afoul of Canadian drug advertising laws
https://www.theglobeandmail.com/canada/article-skinny-inc-online-pharmacy-ads-weight-loss-drugs-federal-rules/?utm_source=dlvr.it&utm_medium=bluesky
1
16
11
reposted by
Chris Hannay
The Globe and Mail
4 months ago
loading . . .
Ottawa says digital prescription tool cancelled because it failed to replace fax machines
Low adoption and the lack of a cost-sharing model ultimately ended the program
https://www.theglobeandmail.com/business/economy/article-digital-prescription-tool-cancelled-failed-to-replace-fax-machines/?utm_source=dlvr.it&utm_medium=bluesky
3
6
6
reposted by
Chris Hannay
The Globe and Mail
4 months ago
loading . . .
Federal âaxe the faxâ e-prescribing service built with Telus Health to shutter after $250-million spent
Launched in 2017, PrescribeIT is live in eight provinces and territories, but usage has remained low despite thousands of pharmacies signing on
https://www.theglobeandmail.com/business/economy/article-federal-axe-the-fax-e-prescribing-service-built-with-telus-health-to/?utm_source=dlvr.it&utm_medium=bluesky
4
7
6
reposted by
Chris Hannay
André Picard @picardonhealth
4 months ago
PrescribeIT, a federal âaxe the faxâ e-prescribing service built with Telus Health, to shutter after $250-million spent, by
@hannay.bsky.social
@kellygrant1.bsky.social
www.theglobeandmail.com/business/eco...
via
@theglobeandmail.com
loading . . .
Federal âaxe the faxâ e-prescribing service built with Telus Health to shutter after $250-million spent
Launched in 2017, PrescribeIT is live in eight provinces and territories, but usage has remained low despite thousands of pharmacies signing on
https://www.theglobeandmail.com/business/economy/article-federal-axe-the-fax-e-prescribing-service-built-with-telus-health-to/
7
17
9
reposted by
Chris Hannay
The Globe and Mail
4 months ago
loading . . .
Drug makers say they are not working with Florida on plan to import Canadian drugs
Florida Governor Ron DeSantis had proposed importing medication from Canada to address high prices
https://www.theglobeandmail.com/business/economy/article-drug-makers-florida-import-drugs-canada-ron-desantis/?utm_source=dlvr.it&utm_medium=bluesky
3
10
12
reposted by
Chris Hannay
The Globe and Mail
4 months ago
loading . . .
Ontarioâs optometrists urge province to expand services they can provide
Ontario Medical Association opposes proposal though optometrists can perform the procedures elsewhere in Canada
https://www.theglobeandmail.com/business/economy/article-ontario-optometrist-procedures-health-care-expand-practice/?utm_source=dlvr.it&utm_medium=bluesky
1
4
2
Sales of GLP-1 drugs have exploded in Canada. We may just be getting started. Sales of Ozempic, Wegovy and Mounjaro totaled nearly $4b in 2025. Generics come out this year. I explore it all in a new feature that launches a series we're calling Skinny Inc:
www.theglobeandmail.com/business/eco...
4 months ago
0
0
1
reposted by
Chris Hannay
The Globe and Mail
4 months ago
loading . . .
How Canada will be a launching pad for the global race for generic Ozempic
Six pharmaceutical companies have applied to make a generic version of semaglutide, and competition will continue to heat up in the rapidly growing weight-loss market
https://www.theglobeandmail.com/business/economy/article-generic-ozempic-canada-drugmakers/?utm_source=dlvr.it&utm_medium=bluesky
0
5
5
reposted by
Chris Hannay
The Globe and Mail
4 months ago
loading . . .
Doctors look to AI to cut burdensome administrative work
In a CMA survey, more than nine in 10 doctors said extra paperwork was harming their professional fulfilment and contributing to burnout
https://www.theglobeandmail.com/business/economy/article-ai-artificial-intelligence-doctors-physicians-hospitals/?utm_source=dlvr.it&utm_medium=bluesky
0
2
1
reposted by
Chris Hannay
The Globe and Mail
5 months ago
loading . . .
Ontario pharmacy regulator sides with teachers insurance plan over prescription exclusivity complaint
Ruling goes against the regulatorâs own zero-tolerance policy on such deals, advocates say
https://www.theglobeandmail.com/business/article-ontario-pharmacy-regulator-teacher-complaint-drug/?utm_source=dlvr.it&utm_medium=bluesky
0
3
2
Some good reminders here, including: stop doomscrolling!
add a skeleton here at some point
5 months ago
0
1
0
reposted by
Chris Hannay
André Picard @picardonhealth
5 months ago
Health Canada considering using decisions of foreign regulators for some drug approvals. Including U.S. FDA on forthcoming list has not been ruled out, by
@kellygrant1.bsky.social
@hannay.bsky.social
www.theglobeandmail.com/canada/artic...
via
@theglobeandmail.com
loading . . .
Health Canada considering using decisions of foreign regulators for some drug approvals
Neither Health Ministerâs office nor federal regulator ruled out including U.S. FDA on forthcoming list
https://www.theglobeandmail.com/canada/article-health-canada-foreign-regulators-drug-approvals/
9
32
28
reposted by
Chris Hannay
The Globe and Mail
5 months ago
loading . . .
Health Canada considering using decisions of foreign regulators for some drug approvals
Neither Health Ministerâs office nor federal regulator ruled out including U.S. FDA on forthcoming list
https://www.theglobeandmail.com/canada/article-health-canada-foreign-regulators-drug-approvals/?utm_source=dlvr.it&utm_medium=bluesky
1
11
4
On the first day generic Ozempic/Wegovy became legal, none of the many generic drug submissions were approved. Novo Nordisk is ready, though, and has just received Health Canada approval for a product it says will challenge its generic competitors.
www.theglobeandmail.com/canada/artic...
loading . . .
Novo Nordisk prepares new cheaper version of Ozempic as generics face delays
Health Canada has yet to approve generics despite applications made as far back as 2024
https://www.theglobeandmail.com/canada/article-ozempic-cheaper-version-novo-nordisk-health-canada-generics/
5 months ago
0
9
1
reposted by
Chris Hannay
The Globe and Mail
5 months ago
loading . . .
Novo Nordisk prepares new cheaper version of Ozempic as generics face delays
Health Canada has yet to approve generics despite applications made as far back as 2024
https://www.theglobeandmail.com/canada/article-ozempic-cheaper-version-novo-nordisk-health-canada-generics/?utm_source=dlvr.it&utm_medium=bluesky
0
14
3
Load more
feeds!
log in
